TFAP2A encodes a TF known to be involved in various cancers (reviewed in ref. 20), including prostate cancer27, 28, where TFAP2A is downregulated, and its promoter is hypermethylated in LNCaP and DU145 model cell lines, as well as in clinical samples27. Here, TFAP2A is linked to cancer.